Ketamine Infusion in a Resistant Obsessive-Compulsive Disorder Patient in Bangladesh with Severe Suicidal Ideation: A Case Report.
Cureus April 1, 2024 Sultana Algin, Debasish Banik, Sm Atikur Rahman et al. 1 citation
A patient with treatment-resistant obsessive-compulsive disorder (OCD) and severe suicidal ideation received three weekly intravenous ketamine infusions. Obsessive-compulsive symptoms and suicidal severity decreased rapidly after the first infusion, though symptoms temporarily increased after a stressful event. Subsequent infusions produced continued improvement, sustained through discharge and at six- and twelve-week follow-ups. The case suggests ketamine may reduce both resistant OCD symptoms and suicidal ideation, though further research is needed.